The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax

Oncogene

Volumn 25, Issue 32, 2006, Pages 4470-4482

  Chevalier, S A ^a   Meertens, L ^a,d   Pise Masison, C ^b   Calattini, S ^a   Park, H ^b   Alhaj, A A ^c   Zhou, M ^b   Gessain, A ^a   Kashanchi, F ^c   Brady, J N ^b   Mahieux, R ^a  

^a INSTITUT PASTEUR   (France)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CREB; HTLV 3; NF B; PDZ; Tax

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PDZ PROTEIN; TAX PROTEIN; TAX1 PROTEIN; TAX2 PROTEIN; TAX3 PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IN VITRO STUDY; LONG TERMINAL REPEAT; LYMPHOPROLIFERATIVE DISEASE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REGULATORY MECHANISM; RETROVIRUS; TAX RESPONSIVE ELEMENT; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CERCOPITHECINAE; GENE PRODUCTS, TAX; HELA CELLS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; PRIMATE T-LYMPHOTROPIC VIRUS 3; SEQUENCE HOMOLOGY, AMINO ACID;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMAN T-LYMPHOTROPIC VIRUS 3; SIMIAN IMMUNODEFICIENCY VIRUS - AGM; SIMIAN T-LYMPHOTROPIC VIRUS 3;

EID: 33746235344     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209472     Document Type: Article

References (64)

1. Alefantis T, Barmak K, Harhaj EW, Grant C, Wigdahl B. (2003). J Biol Chem 278: 21814-21822.
2. Barnhart MK, Connor LM, Marriott SJ. (1997). J Virol 71: 337-344.
3. Blakeslee Jr JR, McClure HM, Anderson DC, Bauer RM, Huff LY, Olsen RG. (1987). Cancer Lett 37: 1-6.
4. Brady J, Jeang KT, Duvall J, Khoury G. (1987). J Virol 61: 2175-2181.
5. Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R et al. (2005). Retrovirology 2: 30.
6. Casoli C, De Lerma Barbaro A, Pilotti E, Bertazzoni U, Tosi G, Accolla RS. (2004). Blood 103: 995-1001.
7. Chen YM, Chen SH, Fu CY, Chen JY, Osame M. (1997). Int J Cancer 71: 196-202.
8. Coates SR, Harris AJ, Parkes DL, Smith CM, Liu HL, Akita RW et al. (1990). J Clin Microbiol 28: 1139-1142.
9. Courgnaud V, Van Dooren S, Liegeois F, Pourrut X, Abela B, Loul S et al. (2004). J Virol 78: 4700-4709.
10. Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade JD et al. (2000). Virology 277: 278-295.
11. Duvall JF, Kashanchi F, Cvekl A, Radonovich MF, Piras G, Brady JN. (1995). J Virol 69: 5077-5086.
12. Endo K, Hirata A, Iwai K, Sakurai M, Fukushi M, Oie M et al. (2002). J Virol 76: 2648-2653.
13. Froment A, Delaporte E, Dazza MC, Larouze B. (1993). AIDS Res Hum Retroviruses 9: 707.
14. Gessain A, Mauclere P, Froment A, Biglione M, Le Hesran JY, Tekaia F et al. (1995). Proc Natl Acad Sci USA 92: 4041-4045.
15. Giri A, Markham P, Digilio L, Hurteau G, Gallo RC, Franchini G. (1994). J Virol 68: 8392-8395.
16. Gitlin SD, Lindholm PF, Marriott SJ, Brady JN. (1991). J Virol 65: 2612-2621.
17. Goubau P, Van Brussel M, Vandamme AM, Liu HF, Desmyter J. (1994). Proc Natl Acad Sci USA 91: 2848-2852.
18. Grassmann R, Dengler C, Muller-Fleckenstein I, Fleckenstein B, McGuire K, Dokhelar MC et al. (1989). Proc Natl Acad Sci USA 86: 3351-3355.
19. Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L. (1995). Proc Natl Acad Sci USA 92: 1057-1061.
20. Guo HG, Wong-Stall F, Gallo RC. (1984). Science 223: 1195-1197.
21. Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, Nakatani Y et al. (1998). Mol Cell Biol 18: 5052-5061.
22. Hirata A, Higuchi M, Niinuma A, Ohashi M, Fukushi M, Oie M et al. (2004). Virology 318: 327-336.
23. Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, Mueller NE. (1998). Blood 92: 3557-3561.
24. Hunsmann G, Schneider J, Bayer H, Jurkiewicz E, Yamamoto N. (1984). Princess Takamatsu Symp 15: 109-118.
25. Iwanaga Y, Tsukahara T, Ohashi T, Tanaka Y, Arai M, Nakamura M et al. (1999). J Virol 73: 1271-1277.
26. Jeang KT, Giam CZ, Majone F, Aboud M. (2004). J Biol Chem 279: 31991-31994.
27. Kashanchi F, Duvall JF, Kwok RP, Lundblad JR, Goodman RH, Brady JN. (1998). J Biol Chem 273: 34646-34652.
28. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, Connor LM et al. (1996). Nature 380: 642-646.
29. Lemasson I, Nyborg JK. (2001). J Biol Chem 276: 15720-15727.
30. Lindholm PF, Marriott SJ, Gitlin SD, Brady JN. (1991). J Biochem Biophys Methods 22: 233-241.
31. Liu HF, Vandamme AM, Van Brussel M, Desmyter J, Goubau P. (1994). Lancet 344: 265-266.
32. Lu H, Pise-Masison CA, Fletcher TM, Schiltz RL, Nagaich AK, Radonovich M et al. (2002). Mol Cell Biol 22: 4450-4462.
33. Mahieux R, Gessain A. (2003). Rev Clin Exp Hematol 7: 336-361.
34. Mahieux R, Ibrahim F, Mauclere P, Herve V, Michel P, Tekaia F et al. (1997). J Virol 71: 1317-1333.
35. Mauclere P, Gessain A, Garcia-Calleja JM, Le Hesran JY, Salla R, Rehle T et al. (1993). Aids 7: 1394-1395.
36. Mauclere P, Le Hesran JY, Mahieux R, Salla R, Mfoupouendoun J, Abada ET et al. (1997). J Infect Dis 176: 505-509.
37. Mboudjeka I, Zekeng L, Yamashita M, Takehisa J, Ido E, Miura T et al. (1997). Jpn J Cancer Res 88: 619-624.
38. Meertens L, Chevalier S, Weil R, Gessain A, Mahieux R. (2004a). J Biol Chem 279: 43307-43320.
39. Meertens L, Gessain A. (2003). J Virol 77: 782-789.
40. Meertens L, Mahieux R, Mauclere P, Lewis J, Gessain A. (2002). J Virol 76: 259-268.
41. Meertens L, Pise-Masison C, Quere N, Brady J, Gessain A, Mahieux R. (2004b). Oncogene 23: 5447-5458.
42. Meertens L, Shanmugam V, Gessain A, Beer BE, Tooze Z, Heneine W et al. (2003). J Gen Virol 84: 2723-2727.
43. Miyoshi I, Yoshimoto S, Fujishita M, Taguchi H, Kubonishi I, Niiya K et al. (1982). Lancet 2: 658.
44. Nerrienet E, Meertens L, Kfutwah A, Foupouapouognigni Y, Ayouba A, Gessain A. (2004). J Gen Virol 85: 25-29.
45. Nerrienet E, Meertens L, Kfutwah A, Foupouapouognigni Y, Gessain A. (2001). J Gen Virol 82: 2973-2977.
46. Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R et al. (2004). Nat Med 10: 197-201.
47. Nourry C, Grant SG, Borg JP. (2003). Sci STKE 2003: RE7.
48. Pise-Masison CA, Brady JN. (2005). Front Biosci 10: 919-930.
49. Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Duvall J, Guillerm C et al. (2000). AIDS Res Hum Retroviruses 16: 1669-1675.
50. Pozzatti R, Vogel J, Jay G. (1990). Mol Cell Biol 10: 413-417.
51. Ross TM, Pettiford SM, Green PL. (1996). J Virol 70: 5194-5202.
52. Rousset R, Fabre S, Desbois C, Bantignies F, Jalinot P. (1998). Oncogene 16: 643-654.
53. Scoggin KE, Ulloa A, Nyborg JK. (2001). Mol Cell Biol 21: 5520-5530.
54. Slattery JP, Franchini G, Gessain A. (1999). Genome Res 9: 525-540.
55. Smith MR, Greene WC. (1990). Genes Dev 4: 1875-1885.
56. Takemura T, Yamashita M, Shimada MK, Ohkura S, Shotake T, Ikeda M et al. (2002). J Virol 76: 1642-1648.
57. Van Brussel M, Goubau P, Rousseau R, Desmyter J, Vandamme AM. (1996). J Gen Virol 77(Part 2): 347-358.
58. Van Brussel M, Goubau P, Rousseau R, Desmyter J, Vandamme AM. (1997). J Virol 71: 5464-5472.
59. Van Brussel M, Salemi M, Liu HF, Goubau P, Desmyter J, Vandamme AM. (1999). Rev Med Virol 9: 155-170.
60. Van Dooren S, Salemi M, Pourrut X, Peeters M, Delaporte E, Van Ranst M et al. (2001). J Virol 75: 11939-11941.
61. Van Dooren S, Shanmugam V, Bhullar V, Parekh B, Vandamme AM, Heneine W et al. (2004). J Gen Virol 85: 507-519.
62. Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M et al. (2005). Blood 106: 2462-2471.
63. Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U et al. (2005). Proc Natl Acad Sci USA 102: 7994-7999.
64. Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL. (2004). J Virol 78: 11077-11083.